Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 1,101–1,200 of 1,392
A New Role for Glucagon: From Secondary Hormone to Key Player
De Fano, M., Malara, M., Rucco, S., Manco, M., Fanelli, C. G., Bolli, G. B., & Porcellati, F. (2025) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104233 · Cited by 1
Komatsu, M., Ekelund, M., Horio, H., & Kadowaki, T. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0606 · Cited by 2
“Severe hypoglycemia was defined accord‐ ing to the American Diabetes Association classification [19], and BG-confirmed hypoglycemia was defined as a plasma glucose value <56 mg/dL (Novo Nordisk A/S definition), with or without symptoms consistent with hypoglycemia.”
MethodPromoting Health and Improving Quality of Life in Diabetes
Martyn-Nemeth, P. A., & Hayman, L. L. (2021) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000842 · Cited by 1
Houssarini, J. A., Brnabic, A. J. M., & Obaid, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01184-x · Cited by 1
“9 mmol/L as measured with a blood glucose meter by the patient in between visits with or without the patient reporting a clear hypoglycaemic symptomatology (presyncope, shakiness, diaphoresis, visual disturbance, nausea, confusion) [13].”
MethodEvaluación del desempeño cognitivo en escolares y adolescentes con diabetes mellitus tipo 1.
Kantar, Y. E., Durán, S., Lanes, R., & Paoli, M. (2023) · Investigación Clínica · doi:10.54817/ic.v64n1a03 · Cited by 4
Garzón, D. V., Forero-Saldarriaga, S., Batancourt, A. M. R., Rojas, J. D. P., Pardo, V. A., Latorre, L. P. F., & Ibáñez‐Pinilla, M. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.02.004 · Cited by 4
Cahyaningsih, I., Asiri, A., de Vos, S., Bos, J., Schuiling‐Veninga, C. C. M., Taxis, K., & Denig, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195855 · Cited by 2
“This suggests that healthcare providers in primary care need to put more effort into regularly assessing the hypoglycaemia burden and adjusting medication treatment to minimize the risk of hypoglycaemia, as suggested by diabetes guidelines [37,38].”
BackgroundGourdy, P., Bonadonna, R. C., Mauricio, D., Müller‐Wieland, D., Mauquoi, C., Vera, C., Bonnemaire, M., & Freemantle, N. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16008 · Cited by 1
“The definitions of hypoglycaemia 28 were predetermined in the current pooled analysis.”
Hjejle, S., Agesen, R. M., Thorsteinsson, B., Pedersen‐Bjergaard, U., & Brøsen, J. M. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40153 · Cited by 1
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
Theys, K., Vermander, S., Annemans, L., Block, C. E. M. D., Hermans, M. P., Matthys, I., Nobels, F. R. E., Nguyen, T. T., Preumont, V., Zakrzewska, K. E., et al. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00547-x · Cited by 2
Recurrent events modeling based on a reflected Brownian motion with application to hypoglycemia
Xie, Y., Fu, H., Huang, Y., Pozdnyakov, V. A., & Yan, J. (2024) · Biostatistics · doi:10.1093/biostatistics/kxae053 · Cited by 2
“9 mmol/l (70 mg/dl), which is the clinical standard for hypoglycemic events (Seaquist et al., 2013).”
BackgroundWorku, Y. B., Tekle, M. T., Bekalu, A. F., & Simegn, M. B. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1320610 · Cited by 1
“Additionally, a hypoglycemic episode that required assistance from another person or medical help in a hospital for corrective measures was categorized as severe hypoglycemia (6).”
Rostampour, K., Sarebanhassanabadi, M., Bidaki, R., Seyedhosseini, S. M., Vasmehjani, A. A., Mohyadini, M., Mirjalili, F. S., & Salehi‐Abargouei, A. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01082-6 · Cited by 1
“Elevated postprandial glucose levels, followed by excessive insulin release, can reduce plasma glucose to approximately ~ 70 mg/dL (3.8 mmol/L), potentially impairing brain glucose availability [73].”
InfluentialJaya, M. K. A., Rahmawati, F., Yasin, N. M., & Ikawati, Z. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998375680250509052027 · Cited by 5
Yang, J.-M., Wang, L., Zhao, X.-F., Ye, Q.-C., Wan, C., Li, X., Huang, R.-F., Peng, R.-R., & Liu, C. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07740-8 · Cited by 1
Aung, N. L. (2025) · Clinical Diabetes · doi:10.2337/cd25-0072 · Cited by 2
Bafail, D. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251410210 · Cited by 1
“56 Functional domains are the most sensitive outcome for detection of subtle effects.”
Quirós, C., Granados, M., César, M. J. P., Nattero‐Chávez, L., Aguilera, E., Mora, M. R. V., Beato-Víbora, P. I., Azriel-Mira, S., Moreno-Fernández, J., Simó‐Servat, O., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261474587 · Cited by 1
Barakat, H. E., Ibrahim, M. A., Warda, A. E. A., Abdelmoneam, M. Y., Sallam, M. F., & Abougalambou, S. S. I. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01211-2 · Cited by 1
“Also, hypoglycemia was associated significantly with insulin and sulfonylurea [59, 60].”
Insulin pumps with a sensor and threshold-suspend reduced nocturnal hypoglycemia in type 1 diabetes
McCoy, R. G., & Smith, S. C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-02007 · Cited by 1
Kim, E. J., Jeong, M. H., Jeong, I. S., Oh, S. G., Kim, S. H., Ahn, Y. K., Kim, J. H., Kim, Y. J., Chae, S. C., Hong, T. J., et al. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.87.5.565 · Cited by 1
¿De qué nos sirve evaluar las tendencias del perfil glucémico ambulatorio?
Izquierdo, E. S. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.06.002 · Cited by 3
FOOS, V., Varol, N., Curtis, B. H., et al. (2015) · Cited by 1
Shimatsu, A. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.683 · Cited by 1
Malek, R., Arbouche, Z., Belhadj, M., Nicolucci, A., & Gari, S. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30070-6 · Cited by 1
Baligar, B. D., Bande, U. S., Kardkal, B. L., Hasabi, I. S., & Anurshetru, S. (2016) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2016/637 · Cited by 1
Islet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_23 · Cited by 2
A Review of Type 1 Diabetes (T1D): To Assist Patients' and Carers' Understanding of This Condition
O’Donnell, E., & O’Donnell, L. (2018) · International Journal of User-Driven Healthcare · doi:10.4018/ijudh.2018070102 · Cited by 1
Lawrence, L., Ali, K. F., Buehler, L. A., Bailey, R. H., Bena, J., Gambino, R. R., & Hamaty, M. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0116 · Cited by 1
Scheen, A. J. (2014) · RMLG. Revue médicale de Liège · Cited by 1
Akute diabetische Stoffwechselentgleisungen
Mertens, M., Dauben, L., Roden, M., & Müssig, K. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1270-8878 · Cited by 1
“Bei 4–10% aller Patienten mit Typ-1-Diabetes ist die Todesursache auf eine Hypoglykämie zurückzuführen [1], hinweisend auf eine hohe Inzidenz und Wichtigkeit dieser Stoffwechselentgleisung.”
BackgroundInfluentialAkram, A. (2021) · Cureus · doi:10.7759/cureus.16112 · Cited by 2
“This patient had symptomatic hypoglycemia, confirmed by the Whipple triad [16], and is by definition "severe hypoglycemia" or "documented symptomatic hypoglycemia" [17].”
BackgroundOut-of-Hospital Management of Diabetic Emergencies in Germany: Structural and Process Quality
Holstein, D. J. F., Holstein, J. D., Fischer, D., Mende, M., Frier, B. M., & Holstein, A. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1523-7562 · Cited by 1
Incidence and Costs of Hypoglycemia among Type II Diabetes Mellitus Patients in Turkey
Fidan, C., Salgür, F., Kul, Ö. E., Bozkuş, Y., Eminsoy, G., Sözen, F., Kut, A., & Öksüz, E. (2021) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1300 · Cited by 1
“Pseudo-hypoglycemia is where any of the typical symptoms are present and the measured PG level is close to 70 mg/dl [12].”
BackgroundManagement of Acute Complications of Diabetes Mellitus
Bae, J. H., & Kim, S. G. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_19 · Cited by 3
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_22 · Cited by 3
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_22 · Cited by 5
Impact of diabetes mellitus on maxillofacial complex and orthodontic treatment
Bampiolaki, M., Zafeiris, C., Rontogianni, A., & Tsolakis, A. I. (2022) · Journal of Research and Practice on the Musculoskeletal System · doi:10.22540/jrpms-06-020 · Cited by 2
Ansari, N. E., Chadli, A., Aziz, S. E., Mghari, G. E., Achhab, Y. E., Seqat, M., & Nejjari, C. (2015) · Journal of Endocrinology and Metabolism · doi:10.14740/jem314w · Cited by 1
van den Berg, E., & Brands, I. (2015) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0417-2_6 · Cited by 1
Ayalew, T. L., Walle, B. G., & Zewudie, B. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275786 · Cited by 4
“Effective methods for lowering the risk of hypoglycemia include patient education and selfmonitoring of blood glucose (SMBG), dietary changes, and regular exercise, medication alterations, careful glucose monitoring by the patient, and attentive clinician follow-up [1, 20, 21].”
MethodHeller, S. R., Battelino, T., Bailey, T. S., Pieber, T. R., Hövelmann, U., Plum‐Mörschel, L., Melgaard, A. E., Aronson, R., DiMeglio, L. A., Johansen, T., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14987 · Cited by 7
Self-citationDiabetes in Children and Adolescents
Lora, A. L. M., Espíndola, M. E., Paz, M. B., Díaz, J. M. M., & Klünder‐Klünder, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_64 · Cited by 1
Stimson, R. H., Dover, A. R., Strachan, M. W. J., Wright, R. J., Lyall, M. J., Jeeyavudeen, M. S., Forbes, S., & Gibb, F. W. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108561 · Cited by 1
Lee, W. K., Ko, M. S. M., Ang, L. C., Zhu, L., Bee, Y. M., Goh, S., & Teh, M. M. (2023) · Diabetic Medicine · doi:10.1111/dme.15215 · Cited by 1
Dei, A., Aldigeri, R., Bellei, G., Raffaeli, D., Bartolo, P. D., Sforza, A., Marchesini, G., Ciardullo, A. V., Manicardi, V., Bianco, M., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02298-x · Cited by 2
“The primary endpoint was the incidence of SHE defined according to ADA criteria as an event requiring assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions [15] during the 12 months.”
BackgroundMethodInfluentialElamin, A., & Teckchandani, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_24 · Cited by 1
(2000) · Time to knit · doi:10.1016/j.ccol.2015.05.017 · Cited by 1
Hypoglycemia and Diabetes: An Update of Current Trends and Treatment
Frazzitta, M. A. (2014) · The Journal of Continuing Education in Nursing · doi:10.3928/00220124-20140925-12 · Cited by 1
Tran, H. T., Thinkhamrop, B., Laohasiriwong, W., & Hurst, C. P. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0379-z · Cited by 1
Visual Symptoms During Hypoglycemia: A Case Series
Sharma, T., Kaur, H., & Weinstock, R. S. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14289.cr · Cited by 1
Treatment Strategy to Prevent Hypoglycemia
Han, S. J. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.30 · Cited by 1
Practical Aspects of Insulin Therapy
Crasto, W., Jarvis, J., & Davies, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-10939-8_6 · Cited by 1
Jeong, J., Yook, S., & Byun, Y. (2016) · Macromolecular Research · doi:10.1007/s13233-016-4110-9 · Cited by 1
Complicaciones agudas hiperglucémicas e hipoglucémicas
Capel, I., & Bergés-Raso, I. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.013 · Cited by 2
Hayashide, J. M., & Buschinelli, J. T. P. (2017) · Revista Brasileira de Saúde Ocupacional · doi:10.1590/2317-6369000128615 · Cited by 4
Hypoglycemia among Insulin-treated Patients with Diabetes: Egypt Cohort of IO HAT Study
Hefnawy, M. H. M. F. E., Abdelaaty, T., Bassyouni, A., Saleem, H. M., Khalid, M., Toaima, D. N., & Maree, M. A. G. (2018) · The Open Diabetes Journal · doi:10.2174/1876524601808010034 · Cited by 1
Silent Hypoglycemia in Patients with Diabetes
Clus, S., Creţeanu, G., & Popa, A. R. (2018) · Internal Medicine · doi:10.2478/inmed-2018-0042 · Cited by 1
Demirtaş, A. O., İçen, Y. K., Koca, H., Sümbül, H. E., Demirtaş, D., Köseoğlu, Z., & Koç, M. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00549-4 · Cited by 2
Netto, A. P. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.09.555752 · Cited by 1
“Summary and Conclusion There are several obstacles and technical errors commonly observed in patients who practice self-administration of insulin, significantly increasing the likelihood of unsuccessful treatments [22-27].”
BackgroundDiabetes and Pregnancy: Risks and Opportunities
Lewis, H., Egerman, R. S., Kazory, A., Sattari, M., & Shurpyak, S. О. (2018) · Family Medicine · doi:10.30841/2307-5112.5.2018.165960 · Cited by 1
Buxton, K., Lix, L. M., Champagne, A., Evans, C. D., Shevchuk, Y. M., Teare, G. F., Mansell, K. D., & Blackburn, D. F. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.10.007 · Cited by 1
Moini, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816864-6.00008-0 · Cited by 1
Jia, X., Meng, F., Pickens, C. J., Thaisrivongs, D. A., Yan, L. Y., Huo, P., Maloney, K. M., & Lin, S. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02249-4 · Cited by 2
Feldman, H. A. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.001 · Cited by 1
Kotsa, K., Kolokas, K., Koufakis, T., Avramidis, I., Gerou, S., Chatzidimitriou, M., & Kazakos, K. (2020) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_80_19 · Cited by 1
“Confirmed hypoglycemic episodes during the past year were self‐reported by the patients on a retrospective basis by completing the “Hypoglycemia Patient Questionnaire” weighted scoring system of the American Diabetes Association, as previously described.[9] In brief, this questionnaire includes questions regarding the…”
BackgroundMethodAnderson, J. E., Urquhart, S., Spollett, G. R., & Dandona, P. (2020) · Clinical Diabetes · doi:10.2337/cd20-0035 · Cited by 1
Self-citationDzida, G. J., & Szczepanik, T. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0015 · Cited by 1
“Severe hypoglycemia was defined according to the American Diabetes Association and the Endocrine Society as glycemia of < 70 mg/dL with symptoms requiring an assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions [10].”
MethodAlotaibi, Y. M., Aldajani, M. F., & Battal, S. A. (2021) · International Journal of Advanced Community Medicine · doi:10.33545/comed.2021.v4.i1a.183 · Cited by 3
Bailey, T. S., Evenou, P., Gill, J., Berhanu, P., Raymond, R., Strong, J. L., & Wright, E. E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0079 · Cited by 1
“Severe hypoglycemia was defined as an event requiring assistance of another person to actively administer carbohydrates or glucagon or take other corrective actions (18) per ADA-defined level 3 hypoglycemia.”
BackgroundThe Effect of Computer-Assisted Glycemic Monitoring Protocol on Workload of Intensive Care Nurses
Canbolat, Ö., & Kapucu, S. (2021) · Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi · doi:10.31125/hunhemsire.1050387 · Cited by 1
“In the literature, many glucose follow-up protocols have been prepared and published within the framework of evidence-based approaches 10,16-19 .”
MethodIslet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_23-1 · Cited by 2
Vas, P. R. J., & Mahdi‐Rogers, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-17918-6_3 · Cited by 1
Hypoglycemia in the Non-diabetic Patient
Hurtado, M. D., & Vella, A. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_34 · Cited by 2
Lakshmi, B., Prabhakar, U., & Sireesha, N. (2022) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20220412 · Cited by 1
Styne, D. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-18371-8_11 · Cited by 1
Bajpai, S., Cambron‐Mellott, M. J., Will, O., Poon, J. L., Wang, Q., Mitchell, B. D., Peck, E. Y., Babrowicz, J., RAIBULET, N. K., Child, C. J., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s367010 · Cited by 1
Parmitasari, Soemarko, D. S., Mokoagow, M. I., & Adi, N. P. (2022) · The Indonesian Journal of Community and Occupational Medicine · doi:10.53773/ijcom.v2i2.64.96-101 · Cited by 1
Sigal, W. M., & León, D. D. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-69415-5.00023-0 · Cited by 1
Palliative and end‐of‐life care
Dunning, T. L., & Sinclair, A. J. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch33 · Cited by 1
Transplantation of Pancreatic Islets
Hering, B. J., & Bellin, M. D. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch147 · Cited by 1
Zhang, P., Zhang, H., Luo, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-228534/v1 · Cited by 1
Chua, M. W. J., Yeoh, E. C. K., Fun, S., & Koh, A. (2021) · Authorea · doi:10.22541/au.161951857.79594520/v1 · Cited by 1
Hypoglycemia Induced Mitochondrial Connexin-43 Accumulation Aggravates Diabetic CardiomyopathyPreprint
Wei, X., Chang, A. C. H., Chang, H., Xu, S., Xue, Y., Zhang, Y., Lei, M., Chang, A. C. Y., & Zhang, Q. (2021) · Research Square · doi:10.21203/rs.3.rs-885699/v1 · Cited by 1
Raine, J., MBChB, J. W. G., Vliet, G. V., MB, B. J. I. W., & Deladoëy, J. (2019) · Wiley eBooks · doi:10.1002/9781119386230.ch1 · Cited by 2
Wu, C., Ge, Y., Xinyan, Z., MingChao, L., Chunni, H., Linyuan, Z., Yanling, D., He, S., Lei, S., & Hongjuan, L. (2021) · Research Square · doi:10.21203/rs.3.rs-200389/v1 · Cited by 2
Acute Complications of Diabetes
Hirsch, I. B., & Childs, B. P. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch09 · Cited by 1
Self-citationHypoglycemia and other complications of insulin therapy
Amiel, S. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch53
Amiel, S. A. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch7
EVALUATING THE ROLE OF HYPOGLYCEMIA & COMORBID ILLNESS ON DIABETES MANAGEMENT BEHAVIORS
Rege, S. V. (2014) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-rege-saumitra-2014
Ampudia‐Blasco, F. J. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.10.001 · Cited by 2
Pampel, S. L. (2015) · Info Diabetologie · doi:10.1007/s15034-015-0519-z
Colás, C. (2013) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(13)70666-7
Meece, J. D., Pearson, T. L., & Siminerio, L. M. (2014) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721714527802
The ups and downs of blood sugar
Morris, D. (2015) · Independent Nurse · doi:10.12968/indn.2015.6.29
Fulcher, G. R., Singer, J., & Filho, F. F. (2014)
Original article A model of mild hypoglycemia
Samuel, S., Goswami, D., Shum, K., Boye, K. S., Rengarajan, B., Curtis, B. H., & Curtis, S. (2015)
Hypoglycaemia: patient inconvenience or serious cardiovascular risk?
(2014) · British Journal of Cardiology · doi:10.5837/bjc.2014.031
Secular and Longitudinal Trends in Body Weight in a Large Population of Veterans, 2000-2014
Tamas, M. J. (2016) · Digital Archive @ GSU · doi:10.57709/7945584
Tavares, H. M. S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/43hv-sd90 · Cited by 1
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.